National Vaccine
Information Center

Your Health. Your Family. Your Choice.

MedAlerts Home
Search Results

Found 413 cases where Vaccine is HPV or HPV2 or HPV4 and Patient Died

Case Details

This is page 24 out of 42

Result pages: prev   15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33   next


VAERS ID: 464985 (history)  
Form: Version 1.0  
Age: 13.0  
Sex: Female  
Location: Foreign  
Vaccinated:2012-08-23
Onset:2012-09-08
   Days after vaccination:16
Submitted: 2012-09-13
   Days after onset:5
Entered: 2012-09-13
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV4: HPV (GARDASIL) / MERCK & CO. INC. G007396 / 2 UN / UN

Administered by: Other       Purchased by: Other
Symptoms: Asthma, Cardiac arrest, Cardio-respiratory arrest, Condition aggravated, Death, Dyspnoea, Electroencephalogram abnormal, Endotracheal intubation, Headache, Hypoxic-ischaemic encephalopathy, Intensive care, Loss of consciousness, Nervous system disorder, Neurological decompensation, Nuclear magnetic resonance imaging abnormal, Resuscitation, Scan abnormal, Vomiting
SMQs:, Torsade de pointes/QT prolongation (broad), Anaphylactic reaction (narrow), Acute pancreatitis (broad), Angioedema (broad), Asthma/bronchospasm (narrow), Hyperglycaemia/new onset diabetes mellitus (broad), Neuroleptic malignant syndrome (broad), Anticholinergic syndrome (broad), Arrhythmia related investigations, signs and symptoms (broad), Ischaemic central nervous system vascular conditions (narrow), Shock-associated circulatory or cardiac conditions (excl torsade de pointes) (narrow), Malignancy related therapeutic and diagnostic procedures (narrow), Acute central respiratory depression (broad), Pulmonary hypertension (broad), Noninfectious encephalitis (broad), Noninfectious encephalopathy/delirium (narrow), Noninfectious meningitis (broad), Gastrointestinal nonspecific symptoms and therapeutic procedures (narrow), Cardiomyopathy (broad), Eosinophilic pneumonia (broad), Hypotonic-hyporesponsive episode (broad), Generalised convulsive seizures following immunisation (broad), Hypersensitivity (broad), Respiratory failure (broad), Hypoglycaemia (broad)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2012-09-08
   Days after onset: 0
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: No other medications
Current Illness: Unknown
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type: WAES1209ESP005292

Write-up: Case received from a healthcare professional, a physician who is a member of the Advisory Board of Vaccination on 10-SEP-2012. A 13 year-old female patient, with a medical history of poorly controlled asthma, had received the second dose of a GARDASIL, batch number not reported, route and site not reported) date not reported. The patient was vaccinated according to the healthcare centre vaccination schedule. It was reported that 12 hours after vaccine administration (exact date not reported), the patient presented with severe asthma. The patient was taken to the hospital where she presented cardio-pulmonary arrest, the patient was transferred to the paediatrician ICU ward of another hospital, where she died. It was reported that the patient had received the first dose of GARDASIL (date of administration not reported), after vaccination the patient''s asthma aggravated. According to the reporter (he was not the physician who treated the patient directly) this case of death was not related to vaccine administration. No further information was reported. Additional information received on 11-SEP-2012, from a healthcare professional, an ICU ward physician who treated the patient: A 13-year-old female patient, born 03-JUL-1999, with a medical history of poorly controlled asthma and allergy to pollen, had received the second dose of GARDASIL, batch number not reported, route and site not reported) on 23-AUG-2012. Previous to vaccine administration and according to the family, the patient presented a mild dyspnea, which she frequently had. According to the reporter, 12 hours after vaccine administration, on 23-AUG-2012, the patient presented with a severe difficulty in breathing and headache. On 23-AUG-2012 at 20:20 hrs, the patient arrived at the healthcare center. The patient was unable to breathe, she vomited once (cessation date 23-AUG-2012) and then she lost consciousness. The patient was transferred to the hospital. She arrived 23 minutes later with asystolia. Cardiac arrest. Cardiopulmonary resuscitation was performed during 12 minutes. The patient was intubated, 3 doses of adrenaline were administered. 17 minutes after they were able to reanimate her. Bronchodilators, Ketamine and Bicarbonate were administered. The patient was transferred in a mobile paediatric intensive care unit to the hospital''s paediatric criteria care unit. MRI and scanners were performed. Neurological lesions were detected. The patient was diagnosed with severe neurological status deterioration and an almost flat encephalogram. On 08-SEP-2012 the patient died. Cause of death was ischemic encephalopathy. The family referred that after the patient had received the first dose of GARDASIL the patient had a mild-moderate asthmatic crisis. According to the reporter, who contacted the patient''s paediatrician, the patient received the first dose of GARDASIL on 27-JUL-2012, route and site not reported, batch number not reported. On 31-JUL-2012 the patient went to the healthcare center to report to her paediatrician that she had presented an asthmatic crisis (date not reported) after vaccination and she had been treated in the hospital. According to the physician who treated the patient in the ICU there is possible relationship between events and vaccination. Further information is expected. Additional information received on 12-SEP-2012, from the physician''s pediatrician: The patient received the first dose of GARDASIL (batch number G007396, route and site not reported) on 23-JUL-2012 (this date is different to the one reported by the ICU pediatrician but it is the one included in the clinical record of the patient at her healthcare centre). According to the pediatrician the patient went to the hospital on the 29-JUL-2012 due to a severe asthmatic crisis where she was treated and controlled. The reporter don''t know if the patient was admitted to hospital or treated at the emergency room. No further information on this episode was reported. On 31-JUL-2012 the patient attended his office to report the episode. At that time the patient was well. On 23-AUG-2012 the patient was administered the second dose of GARDASIL (batch number G007396, route and site not reported). According to the clinical record of the patient she had history of allergic asthma, not controlled because she did not follow the recommended treatment (prophylaxis with SYMBICORT), allergy to acaridae. The patient had frequent moderate exacerbations and previous episodes of bronchitis since year 2010, which is the date since the pediatrician had patient history. The patient had history of intrauterine growth retardation and short stature. According to the pediatrician opinion relationship of adverse events and vaccination is unknown. No further information is reported.


VAERS ID: 467780 (history)  
Form: Version 1.0  
Age: 31.0  
Sex: Female  
Location: Foreign  
Vaccinated:2005-11-01
Onset:2010-01-15
   Days after vaccination:1536
Submitted: 2012-10-04
   Days after onset:992
Entered: 2012-10-05
   Days after submission:1
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV2: HPV (CERVARIX) / GLAXOSMITHKLINE BIOLOGICALS - / 3 LA / UN

Administered by: Other       Purchased by: Other
Symptoms: Abdominal pain upper, Biopsy stomach abnormal, Chemotherapy, Gastrectomy, Gastric cancer, Metastases to ovary, Radiotherapy
SMQs:, Acute pancreatitis (broad), Malignancy related therapeutic and diagnostic procedures (narrow), Gastrointestinal perforation, ulcer, haemorrhage, obstruction non-specific findings/procedures (broad), Gastrointestinal nonspecific symptoms and therapeutic procedures (narrow), Non-haematological malignant tumours (narrow)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2012-07-12
   Days after onset: 908
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type:

Write-up: In 11/2009, subject reported onset of severe epigastralgia and was examined and biopsied on 01/15/2010. After receiving Dx of gastric cancer, had complete gastrectomy on 2/9/2010 and 45 day hospital stay. Was also hospitalized in 4/2010 for chemotherapy and radiotherapy, and discharged on 5/26/2010. Followed up with specialist, chemotherapy, and metoclopramide daily. Mother reported subject received Dx of ovarian metastasis in 4/2011, and additional chemotherapy was not successful.


VAERS ID: 471789 (history)  
Form: Version 1.0  
Age:   
Sex: Unknown  
Location: Foreign  
Vaccinated:0000-00-00
Onset:0000-00-00
Submitted: 2012-10-26
Entered: 2012-10-26
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV4: HPV (GARDASIL) / MERCK & CO. INC. - / UNK UN / UN

Administered by: Other       Purchased by: Other
Symptoms: Death
SMQs:

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 0000-00-00
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: No other medications
Current Illness: Unknown
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type: WAES1210HKG011628

Write-up: This spontaneous report as received from a consumer, who learnt from a radio channel of fatal cases after GARDASIL vaccination (121USA012211) and (2 fatal cases, this case) and (3 fatal cases, 1210USA012210). The reporter himself experienced serious adverse events (1210HKG011385). This report refers to three patients of unknown age. The patients were vaccinated with GARDASIL (date and route of administration not provided). No other co-suspects were reported. No concomitant medications were reported. On an unknown date the patients died. No details for death are available. The relatedness for death is unknown for GARDASIL. Additional information has been requested.


VAERS ID: 475457 (history)  
Form: Version 1.0  
Age:   
Sex: Female  
Location: Foreign  
Vaccinated:2011-05-20
Onset:2011-10-14
   Days after vaccination:147
Submitted: 2012-11-27
   Days after onset:410
Entered: 2012-11-27
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HEP: HEP B (ENGERIX-B) / GLAXOSMITHKLINE BIOLOGICALS - / 1 RA / UN
HPV2: HPV (CERVARIX) / GLAXOSMITHKLINE BIOLOGICALS - / 1 RA / UN

Administered by: Other       Purchased by: Other
Symptoms: Anomaly of external ear congenital, Biopsy, Death neonatal, Foetal exposure timing unspecified, Limb malformation, Multiple congenital abnormalities, Oligohydramnios, Premature baby, Skeletal dysplasia, Skin exfoliation, Skin oedema
SMQs:, Severe cutaneous adverse reactions (broad), Angioedema (broad), Congenital, familial and genetic disorders (narrow), Acute central respiratory depression (broad), Haemodynamic oedema, effusions and fluid overload (narrow), Pregnancy, labour and delivery complications and risk factors (excl abortions and stillbirth) (narrow), Foetal disorders (narrow), Neonatal disorders (narrow), Hypersensitivity (broad), Respiratory failure (broad), Drug reaction with eosinophilia and systemic symptoms syndrome (broad)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 0000-00-00
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? Yes
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: Folic acid; Iron salt; Indomethacin; Ampicillin trihydrate; Dinoprost trometamol; Intravenous fluids; Oxytocin
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data: Biopsy, 17Oct2011, see lab text; Fetal heart rate, 13Oct2011, 161 per minute; Fetal heart rate, 13Oct2011, 151 per minute; Sonogram, 14Oct2011, see lab text 14 October 2011: She had a sonogram performed which showed: alive baby, dimorphic with the following findings: A) cephalic baby with a cephalic circumference that remembers the image of a strawberry, with a extremely thin bone table, with a mean gestational age of 26 weeks and with an important skin edema above the skull. At central nervous system as a single finding is observed a decreased differentiation of wrinkles. B) Heart exam: atrial rhythm 156 per minute (min), ventricular rhythm 143 min, arrhythmic, it seems to have a disorder due to an atrioventricular node block. Structurally is a heart of 4 chambers with AV and VA concordance, outflow tracts without obstructions and normal aortic arch are observed. C) seems to have a narrow chest with a circumpherence of 12 cm with levocardia. Diaphragm intact. No pleural or pericardic effusion. D) Important ascytic with intestine with echogenic internal areas, liver with echogenic areas or points, at the examination of the venous ductus is noted a "a" negative wave. Spinal cord closed without defects at lumbar or sacral levels. Kidneys of normal aspect. In upper as well as in lower limbs important macromelia. In distal as well as in proximal segments rizomelia and mesomelia. Is not possible the analysis of hands and face due to an important oligohydramnios. Diagnostic impression: 1) considering the findings of narrow chest and macromelia, with a convex forehead and a not oval skull the most probable diagnosis is a thanatophoric dysplasia, 2) severe oligohydramnios, 3) growth of 26 weeks by cephalic circumpherence, 4) abdominal circumpherence and longitudinal femoral are not valid. 17 October 2011: Biopsy 11-9099. Specimen: placental remains. Diagnosis: decidua. 17 October 2011: Biopsy 11-9134. Specimen: fetus. Diagnosis female fetus of approximately 21 weeks of gestational age, multiple external malformations, 400g, 26 cm, of macerated aspect, slough skin with low set ears, ogival palate, short limbs.
CDC Split Type: A0933003B

Write-up: This female subject was enrolled in the study sponsored by the National Cancer Institute (NCI). On 20 May 2011, the subject received the 1st dose of CERVARIX and ENGERIX B in her right deltoid. The serious adverse event described below was not experienced by a study subject but her offspring. The study subject or mother was exposed to CERVARIX and ENGERIX B before conception. The mother took concomitant medications iron, folic acid, PROSTIN, oxytocin, iron, indomethacin, IV fluids, folic acid and ampicillin during her pregnancy. The mother had the following relevant medical conditions: SAE of therapeutic miscarriage (see case A0933003A for more details). On 14 October 2011, five months after the mother (subject) took the 1st dose of CERVARIX and the 1st dose of ENGERIX B, the subject''s fetus was diagnosed with multiple congenital malformations. The event was a congenital anomaly, clinically significant (or requiring intervention) and resulted in a fatal outcome. Due to the multiple congenital anomalies elective termination of pregnancy was decided on 17 October 2011. The investigator reported the multiple congenital malformations as possibly related to CERVARIX and ENGERIX B given the short time that elapsed between the last done of the vaccine and the last menstrual period (LMP). Investigator comments: Last menstrual period (LMP): 23 May 2011, total of seven pregnancies, five deliveries and one previous miscarriage. The subject (mother) used oral contraception before becoming pregnant. She only attended one prenatal care appointment. On 16 November 2011, the subject reported by phone that on 14 October 2011 she was hospitalized due to threatened preterm delivery (see serious adverse event number 60411). On 17 October 2011, when she was 21 weeks of gestational age she had induced a vaginal delivery and she gave birth to a preterm female newborn, weight 400 grams, length 23.5 centimeters, Apgar score unknown, who died some minutes after delivery. The medical chart will be reviewed as soon as possible. Diagnosis: prematurity. Investigator comments received on 22 November 2012: To follow up the serious adverse event 60446, with diagnosis of prematurity, on 21 November 2012 the medical chart was reviewed in a local hospital and the following was found: 13 October 20121: Referred from a primary care center to the emergency room (ER): gestational age: 20 weeks, with history of abundant vaginal bleeding. Physical examination: Normal BP, without fever, pelvic exam: 1 cm of dilation, vaginal bleeding (negative), hydrorrhea (positive), fetal heart rate: 161 per minute (min), fetal movements (positive). Diagnostic impression: threatened miscarriage. At the ER: delayed miscarriage. Pelvic exam: 1 cm of dilation, mild vaginal bleeding, fetal heart rate: 151 min. Plan: admission, ward routine, Indomethacin. Diagnosis of admission: delayed threatened miscarriage. 14 October 2011: She had a sonogram performed which showed: alive baby, dimorphic with the following findings: A) cephalic baby with a cephalic circumference that remembers the image of a strawberry, with a extremely this bone table, with a mean gestational age of weeks and with an important skin edema above the skull. At central nervous system as a single finding is observed a decreased differentiation of wrinkles. B) Heart exam: atrial rhythm 156 min, ventricular rhythm 143 min, arrhythmic, it seems to have a disorder due to an atrioventricular node block. Structurally is a heart of 4 chambers with AV and VA concordance, outflow tracts without obstructions and normal aortic arch are observed. C) seems to have a narrow chest with a circumference of 12 cm with levocardia. Diaphragm intact. No pleural or pericardic effusion. D) Important ascytis with intestine with echogenic internal areas, liver with echogenic areas or points, at the examination of the venous ductus is noted "a" negative wave. Spinal cord closed without defects at lumbar or sacral levels. Kidneys of normal aspect. In upper as well as in lower limbs important macromelia. In distal as well as in proximal segments rizomelia and mesomelia. Is not possible the analysis of hands and face due to an important oligohydramnios. Diagnostic impression: 1) considering the findings of narrow chest and macromelia, with a convex forehead and a not oval skull the most probable diagnosis is a thanatophoric dysplasia, 2) severe oligohydramnios, 3) growth of 26 weeks by cephalic circumference, 4) abdominal circumference and longitudinal femoral are not valid. Plan: the progress is explained to the patient, sterile clothe, lab tests. 15 October 2011: Is indicated: temperature measurement curve, ampicillin. 16 October 2011: Informed consent for therapeutic miscarriage is completed. Plan: PROSTIN gel, IV solution and oxytocin. 17 October 2011: She underwent dilation and curettage and biopsy. Pre and post surgical diagnosis: incomplete miscarriage. Plan: post surgical protocol, diclofenac, cephalothin, ampicillin, schedule for bilateral tubal occlusion by request of the patient, transfuse PRBC. On 18 October 2011, 19 October 2011 and 20 October 2011 hospitalized due to bilateral tubal occlusion. Diagnosis of discharge: delayed miscarriage, multiple fetal malformations, premature rupture of membranes, satisfied parity. Diagnosis: female fetus of approximately 21 weeks of gestational age, multiple external malformations, 400 grams (g), 26 centimeters (cm), of macerated aspect, slough skin with low set ears, ogival palate, short limbs. Given the information obtained the onset date and the diagnosis change. Considering that the diagnosis of the event changes to multiple malformations in the participant''s daughter and given the short time elapsed between the vaccination and the LMP we decided to change the relation with the vaccine as "possibly related". Diagnosis: multiple congenital multiple malformations in the participant''s daughter.


VAERS ID: 477609 (history)  
Form: Version 1.0  
Age:   
Sex: Unknown  
Location: Foreign  
Vaccinated:0000-00-00
Onset:0000-00-00
Submitted: 2012-12-11
Entered: 2012-12-11
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV4: HPV (GARDASIL) / MERCK & CO. INC. - / UNK UN / UN

Administered by: Other       Purchased by: Other
Symptoms: Death
SMQs:

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 0000-00-00
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: No other medications
Current Illness: Unknown
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type: WAES1212CAN002771

Write-up: This unconfirmed spontaneous report as received from a nurse, who obtained the information from the internet, refers to 47 patients of unknown age. The patients were vaccinated with GARDASIL on unknown dates. No other co-suspects and no concomitant medications were reported. The nurse mentioned 47 deaths as a result of patients getting GARDASIL. No treatment information was reported. The outcome of she mentioned 47 deaths as a result of patients getting GARDASIL was reported as fatal. No details for death are available. The relatedness for she mentioned 47 deaths as a result of patients getting GARDASIL is unknown for GARDASIL. Additional information is not expected.


VAERS ID: 478227 (history)  
Form: Version 1.0  
Age:   
Sex: Female  
Location: Foreign  
Vaccinated:2012-11-25
Onset:2012-12-01
   Days after vaccination:6
Submitted: 2012-12-17
   Days after onset:16
Entered: 2012-12-17
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV4: HPV (GARDASIL) / MERCK & CO. INC. - / 2 UN / UN

Administered by: Other       Purchased by: Other
Symptoms: Death, Oedema peripheral, Swelling
SMQs:, Cardiac failure (broad), Anaphylactic reaction (broad), Angioedema (broad), Haemodynamic oedema, effusions and fluid overload (narrow)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2012-12-17
   Days after onset: 16
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: No other medications
Current Illness: Unknown
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type: WAES1212NPL005349

Write-up: This spontaneous report as received from a physician via a business partner refers to a female patient of unknown age. The patient was vaccinated with the second dose of GARDASIL (lot number, dose, route, and strength were not reported). on 25-NOV-2012. No other co-suspects were reported. No concomitant medications were reported. Following the vaccination on that evening, on 25-NOV-2012, the patient had little bit of swollen hand. She did not come to her class the next day, but a day after that, she had been moving around and attending her classes. But on 29-NOV-2012, her body was swollen and she died on 01-DEC-2012. The outcome of swollen hand and swollen body was unknown. The patient''s death was confirmed, her parents did not file any complain and the physician was told that it was not in relation with the vaccine administration. Based on the written field report the physician got from the local program coordinator, the death was not caused by vaccination. Additional information is not expected.


VAERS ID: 479323 (history)  
Form: Version 1.0  
Age:   
Sex: Female  
Location: Foreign  
Vaccinated:0000-00-00
Onset:0000-00-00
Submitted: 2012-12-26
Entered: 2012-12-26
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV4: HPV (GARDASIL) / MERCK & CO. INC. - / UNK UN / UN

Administered by: Other       Purchased by: Other
Symptoms: Death
SMQs:

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 0000-00-00
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: No other medications
Current Illness: Immunisation
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type: WAES1212GBR009750

Write-up: This invalid case (multiple unknown patients) a hearsay report was received from a consumer on 12-DEC-2012. This case is not medically confirmed. Up to 200 girls received injections of GARDASIL (batch number not reported), route and site not reported, on an unreported date. The reporter stated that the girls were killed outright and that tens of thousands of others were injured. The outcome of the injured girls was not reported.


VAERS ID: 482106 (history)  
Form: Version 1.0  
Age:   
Sex: Unknown  
Location: Foreign  
Vaccinated:0000-00-00
Onset:0000-00-00
Submitted: 2013-01-22
Entered: 2013-01-22
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV4: HPV (GARDASIL) / MERCK & CO. INC. - / UNK UN / UN

Administered by: Other       Purchased by: Other
Symptoms: Unevaluable event
SMQs:

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 0000-00-00
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: No other medications
Current Illness: Unknown
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type: WAES1301ISR008834

Write-up: This spontaneous social media report refers to few patients of unknown age and gender. On an unknown date, the patients were vaccinated with a dose of GARDASIL (lot number, expiry date, dose, route unspecified). No concomitant medications were reported. Few fatal cases post vaccination were reported on an unknown date (query pending). Cause and other details of death were unknown. The relatedness for few fatal cases post vaccination was unknown for GARDASIL. Additional information has been requested.


VAERS ID: 487130 (history)  
Form: Version 1.0  
Age:   
Sex: Female  
Location: Foreign  
Vaccinated:2011-09-01
Onset:0000-00-00
Submitted: 2013-03-18
Entered: 2013-03-18
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV2: HPV (CERVARIX) / GLAXOSMITHKLINE BIOLOGICALS - / UNK LA / IM

Administered by: Other       Purchased by: Other
Symptoms: Completed suicide
SMQs:, Suicide/self-injury (narrow)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 0000-00-00
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness: Unknown
Preexisting Conditions:
Allergies:
Diagnostic Lab Data: UNK
CDC Split Type: B0875158A

Write-up: This case was reported by a physician and described the occurrence of suicide in a female subject of unspecified age who was vaccinated with CERVARIX (GlaxoSmithKline). In September 2011, the subject received an unspecified dose of CERVARIX (intramuscular, unknown injection site, batch number not provided). At an unspecified time after vaccination with CERVARIX, the subject committed suicide. The suicide was accomplished. It was unknown whether an autopsy was performed. No further information could be obtained. Case was closed.


VAERS ID: 487849 (history)  
Form: Version 1.0  
Age: 0.2  
Sex: Unknown  
Location: Foreign  
Vaccinated:2013-01-05
Onset:2013-02-27
   Days after vaccination:53
Submitted: 2013-03-26
   Days after onset:26
Entered: 2013-03-27
   Days after submission:1
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV4: HPV (GARDASIL) / MERCK & CO. INC. - / 3 UN / UN

Administered by: Other       Purchased by: Other
Symptoms: Abortion, Exposure during pregnancy, Foetal death, Foetal disorder
SMQs:, Pregnancy, labour and delivery complications and risk factors (excl abortions and stillbirth) (narrow), Foetal disorders (narrow), Termination of pregnancy and risk of abortion (narrow)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2013-02-27
   Days after onset: 0
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? Yes
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: No other medications
Current Illness: Unknown
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type: WAES1303JPN010510

Write-up: Initial information has been received from a physician concerning a fetus patient. The patient''s mother on 05-JAN-2013 was vaccinated with the third injection of GARDASIL injection drug (injection site, dose and indication not reported). The information on concomitant medication was not reported. On 06-JUL-2012, the patient''s mother was vaccinated with the first injection. On 04-SEP-2012, the patient''s mother was vaccinated with the second injection. On 05-JAN-2013, the patient''s mother was vaccinated with the third injection. The patient''s mother was vaccinated at other health-care facility, after that visited the hospital. The last menses date was 03-JAN-2013. On 27-FEB-2013, the patient''s mother developed abortion. Gestational duration was 7 weeks. The cause of fetus''s death was an abortion by congenital anomaly. The reporting physician considered that the abortion was serious due to death and congenital anomaly. The reporting physician felt that the relationship between abortion and GARDASIL was unknown. Additional information has been requested.


Result pages: prev   15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33   next

New Search

Link To This Search Result:

https://www.medalerts.org/vaersdb/findfield.php?EVENTS=ON&PAGENO=24&VAX[]=HPV&VAX[]=HPV2&VAX[]=HPV4&DIED=Yes


Copyright © 2020 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166